Before revision:  We apply this approach to calculate the likelihood that  cholesterol binds to widely-studied crystallographic sites on 3 GPCRs (beta2-adrenergic, 5HT-2B, and mu-opioid) at a range of concentrations.
After revision:  We apply this approach to calculate the likelihood that cholesterol binds to known crystallographic sites on 3 GPCRs (beta2-adrenergic, 5HT-2B, and mu-opioid) at a range of concentrations.